Vyvanse which is prescribed as a treatment for attention-deficit hyperactivity disorder (ADHD) is an amphetamine-based drug. In 1997, it was brought to the U.S. as a treatment for ADHD with its generic name Lisdexamfetamine. The drug was produced as a less potent but more effective alternative to Ritalin and Adderall which are other amphetamine-based ADHD drugs. It is unfortunate that a lot of persons tend to struggle with Vyvanse addiction.
Time-released properties are present in Vyvanse formulation making its initial effects in its users lengthier and less instantaneous. Throughout the day, little amounts of its active ingredients are gradually released over time. It was more marketable and seen as a more efficient way of treating ADHD because of this feature since patients were able to take one dose daily than taking medications such as Ritalin and Adderall several times a day.
Several persons with a Vyvanse addiction tamper with the time-released formation by clearing out the Vyvanse capsules and inhaling the drug.